Hematology Diagnostics Market: Rising Popularity of Medical Tourism Providing Impetus to Market Growth: Global Industry Analysis (2013-2017) and Opportunity Assessment (2018-2026)
- REP-GB-9046
- 2019-03-12
- Category: Healthcare, Pharmaceuticals and Medical devices
- 228 Pages
- Format:
Hematology Diagnostics Market- Prevalence of Blood-Related Disorders to Propel Demand
Hematology refers to a diagnostic bifurcation of cells found in the blood, which is helpful for easy and effective identification of various disease-causing pathogens. The process of hematology diagnosis consists of the calculation of RBC, WBC, and platelet count. The hematology diagnosis process is associated with effective monitoring of diseases, prognosis & diagnosis, and subsequent screening. Growing prevalence of blood-related disorders and rising demand for technologically-advanced methodologies are among the prime factors fuelling investments in hematology diagnosis market.
Rising consolidation among leading market players & diagnostic laboratories is another chief aspect predominantly responsible for growth of hematology diagnostics market over the forecast period. Ever-evolving expansion of the hematology diagnostics market can be ascribed to rise in prevalence of blood-related disorders, which, in turn, results in augmented demand for effective diagnostics, such as hematology diagnostics.
Hematology Diagnostics Market- Manufacturers to Focus on Novel Product Developments Aligned with End-User Requirements
Sensing varying requirements of end-users, the manufacturers operating in the hematology market are vying to offer new products well-aligned with end-user requirements. This is resulting in an extensive inflow of new analyzers and combinations with effective functionalities and testing parameters. Moreover, key companies operating in the hematology diagnostics market are vying to be cost-competitive by commercializing their products at competitive prices.
With on-going developments in the flow cytometry procedures and techniques, manufacturers in the hematology diagnostics market are offering differential equipment for effective identification and detection of immature cells. In addition, with various improvement in case of electronic-fluidic systems, demand from laboratories for compact and cost-effective hematology diagnostics equipment is significantly taking off.
Hematology Diagnostics Market- Ubiquitous Demand for Medical Tourism to Boost Growth
Affordability combined with easy accessibility of effective healthcare services is resulting in heightened demand for medical tourism and medical equipment, including hematology diagnostics systems. Growing prevalence of blood-associated disorders in remote areas and skyrocketing demand for effective diagnosis via medical tourism is likely to provide impetus to growth of hematology diagnostics market. Availability of latest and advanced equipment & technologies has restored the confidence of patients to opt for medical tourism hubs, creating opportunities for manufacturers in hematology diagnostics market.
Hematology Diagnostics Market- North America Continues to Retain its Lucrativeness, US and Canada to Offer Profit-Making Opportunities
North America continues to retain its position as a lucrative market for hematology diagnostics, offering sustained opportunities for the key stakeholders of hematology diagnostics market. With a major chunk of the global market share in 2017, multimodal factors, including advancements in healthcare space, high awareness ratio, and favorable reimbursement scenarios, are making North America a profitable region in the hematology diagnostics market space.
The U.S. & Canada continue to be progressive North American countries staying at the forefront of research and technological innovations, offering immense scope for revenue growth of hematology diagnostics market. This, in turn, is encouraging the participants of hematology diagnostics market to expand their foothold and tap into new customer segments across the key countries of North America.
Hematology Diagnostics Market- The Competitive Landscape
The report on hematology diagnostics market profiles key companies operating in the global market space, by analyzing their key differential strategies. Some of the leading players operating in the hematology diagnostics market include Sysmex Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., Mindray Medical International Limited, Sysmex Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers, HemoCue AB, HORIBA, Ltd., Danaher (Beckman Coulter, Inc.), and others.
The leading market players are investing in research and development and embracing advanced technologies, with an objective of diversifying their product portfolio, expanding their customer outreach, and extend their regional presence.
The report on hematology diagnostics market offers an incisive analysis of the global hematology diagnostics market over the forecast period of 2018 to 2026. The report on hematology diagnostics market sheds light on prime opportunities brimming in the hematology diagnostics market during the forecast timespan, for the readers to take into account. The report on hematology diagnostics market offers a deep-dive into a comprehensive segmental analysis, wherein every segment has been analyzed and presented on the basis of their attractiveness in the hematology diagnostics market space.
The segmentation offered in the research study on hematology diagnostics market is presented on the basis of end-user, product type, and region. On the basis of product type, the hematology diagnostics market has been bifurcated into hematology consumables and hematology instruments. On the basis of end-user, the hematology diagnostics market has been bifurcated on diagnostic laboratories, academic institutes, hospitals & clinics, and others. On the basis of region, the hematology diagnostics market has been gauged across regions of North America, Asia Pacific, Latin America, Europe, and MEA (Middle East & Africa).
The research methodology for hematology diagnostics market report is solely based on both primary and secondary research phases, which are the key steps carried out to garner useful insights with respect to hematology diagnostics market growth. The insights collected and compiled in the hematology diagnostics market report are instrumental for analyzing growth of hematology diagnostics market. Primary research represents a crucial part of the overall research methodology for hematology diagnostics market report, wherein in-person interviews and constructive discussions with industry experts and opinion leaders are carried out. The phase of secondary research consists of a comprehensive study of various relevant sources, including annual reports, investor presentations, paid databases, and company websites. The report on hematology diagnostics market gives data insights, for both value and volume, and also considers the macro and micro economic trends for determining growth of hematology diagnostics market.
The research report on hematology diagnostics market comprises of a detailed executive summary, wherein a quick snapshot is offered to understand the market progress. The executive summary also comprises of information and insights on various market segments, wherein different segments along with their growth prospects have been analyzed. The various products segments analyzed in detail in the hematology diagnostics market report include product type, region, and end-user. The section of market overview in the hematology diagnostics market report offers a detailed analysis of the market dynamics, including trends, opportunities, challenges, and drivers, which play a profound role in shaping growth of hematology diagnostics market. The report on hematology diagnostics market also offers a model of Porter’s five forces, which offers a deep-dive into the competitive landscape of hematology diagnostics market.
The competitive landscape section in the hematology diagnostics market report offers a detailed analysis of market share of various players operating in the global market space, along with other details such as differential strategies, revenue details, regional presence, and product developments. On the basis of region, the growth of hematology diagnostics market has been analyzed and examined across various key regions, including North America, Asia Pacific, Latin America, Europe, and MEA (Middle East & Africa). The regional analysis in the hematology diagnostics market report offers a comprehensible view of various countries and associated growth opportunities for the better understanding of readers.
The report on hematology diagnostics market also includes profiles of leading players operating in the market on the basis of multiple aspects, including company and financial overview, product portfolios, differential strategies, and novel product developments.
Hematology Diagnostics Market Reports - Table of Contents
Section 01 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section 02 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology
Section 03 Executive Summary
3.1 Global Hematology Diagnostics Market Size (US$ Mn) and Distribution by Geography, 2017 and 2026
3.2 Global Hematology Diagnostics Market Snapshot, 2017
3.3 Global Hematology Diagnostics Market: Opportunity Map
Section 04 Market Overview
4.1 Overview
4.2 Global Hematology Diagnostics Market Size (US$ Mn) Forecast, 2016–2026
4.3 Global Hematology Diagnostics Market Outlook
4.4 Global Hematology Diagnostics Market: Porter’s Five Forces Analysis
4.5 Hematology Analyzers Installed Base
4.6 Key Success factor for Top 3 Players
4.7 Technological Advancements
4.8 Disease Prevalence & Incidence Rate Globally with Key Countries
Section 05 Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Opportunity Analysis
5.4 Opportunities
5.5 Trends
Section 06 Hematology Diagnostics Market Analysis, by Product Type
6.1 Introduction
6.2 Global Hematology Diagnostics Market Value Share Analysis, by Product Type
6.3 Hematology Diagnostics Market Analysis, by Product Type
6.3.1 Hematology Instruments
6.3.1.1 Hematology Analyzers
6.3.1.1.1 Fully-automated Hematology Analyzers
6.3.1.1.2 Semi-automated Hematology Analyzers
6.3.1.2 Flow Cytometers
6.3.1.3 Others
6.3.2 Hematology Consumables
6.3.2.1 Reagents
6.3.2.2 Stains
6.3.2.3 Controls & Calibrators
6.3.2.4 Others
6.4 Hematology Diagnostics Market Attractiveness Analysis, by Product Type
6.5 Hematology Diagnostics Market Attractiveness Analysis, by Hematology Analyzers
6.6 Hematology Diagnostics Market Attractiveness Analysis, by Hematology Consumables
Section 07 Hematology Diagnostics Market Analysis, by End-user
7.1 Introduction
7.2 Global Hematology Diagnostics Market Value Share Analysis, by End-user
7.3 Hematology Diagnostics Market Analysis, by End-user
7.3.1 Diagnostic Laboratories
7.3.2 Hospitals & Clinics
7.3.3 Academic Institutes
7.3.4 Others
7.4 Hematology Diagnostics Market Attractiveness Analysis, by End-user
Section 08 Hematology Diagnostics Market Analysis, by Region
8.1 Global Hematology Diagnostics Market Snapshot, by Country
8.2 Global Hematology Diagnostics Market Value Share Analysis, by Region
8.3 Hematology Diagnostics Market Forecast, by Region
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Latin America
8.3.5 Middle East & Africa
8.4 Hematology Diagnostics Market Attractiveness Analysis, by Region
8.5 Hematology Diagnostics Market: Regional Trends
Section 09 North America Hematology Diagnostics Market Analysis
9.1 Key Findings
9.2 North America Hematology Diagnostics Market Overview
9.3 North America Market Value Share Analysis, by Product Type
9.4 North America Market Forecast, by Product Type
9.4.1 Hematology Instruments
9.4.2 Hematology Consumables
9.5 North America Market Value Share Analysis, by Hematology Instruments
9.6 North America Market Forecast, by Hematology Instruments
9.6.1 Hematology Analyzers
9.6.2 Flow Cytometers
9.6.3 Others
9.7 North America Market Value Share Analysis, by Hematology Consumables
9.8 North America Market Forecast, by Hematology Consumables
9.8.1 Reagents
9.8.2 Stains
9.8.3 Controls & Calibrators
9.8.4 Others
9.9 North America Market Value Share Analysis, by End-user
9.10 North America Market Forecast, by End-user
9.10.1 Diagnostic Laboratories
9.10.2 Hospitals & Clinics
9.10.3 Academic Institutes
9.10.4 Others
9.11 Market Analysis, by Country
9.12 Market Value Share Analysis, by Country
9.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026
9.13.1 U.S.
9.13.2 Canada
9.14 Market Attractiveness Analysis
9.14.1 by Product Type
9.14.2 by Hematology Instruments
9.14.3 by Hematology Consumables
9.14.4 by End-user
9.14.5 by Country
Section 10 Europe Hematology Diagnostics Market Analysis
10.1 Key Findings
10.2 Europe Hematology Diagnostics Market Overview
10.3 Europe Market Value Share Analysis, by Product Type
10.4 Europe Market Forecast, by Product Type
10.4.1 Hematology Instruments
10.4.2 Hematology Consumables
10.5 Europe Market Value Share Analysis, by Hematology Instruments
10.6 Europe Market Forecast, by Hematology Instruments
10.6.1 Hematology Analyzers
10.6.2 Flow Cytometers
10.6.3 Others
10.7 Europe Market Value Share Analysis, by Hematology Consumables
10.8 Europe Market Forecast, by Hematology Consumables
10.8.1 Reagents
10.8.2 Stains
10.8.3 Controls & Calibrators
10.8.4 Others
10.9 Europe Market Value Share Analysis, by End-user
10.10 Europe Market Forecast, by End-user
10.10.1 Diagnostic Laboratories
10.10.2 Hospitals & Clinics
10.10.3 Academic Institutes
10.10.4 Others
10.11 Market Analysis, by Country
10.12 Market Value Share Analysis, by Country
10.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026
10.13.1 Germany
10.13.2 France
10.13.3 U.K.
10.13.4 Italy
10.13.5 Spain
10.13.6 Rest of Europe
10.14 Market Attractiveness Analysis
10.14.1 by Product Type
10.14.2 by Hematology Instruments
10.14.3 by Hematology Consumables
10.14.4 by End-user
10.14.5 by Country
Section 11 Asia Pacific Hematology Diagnostics Market Analysis
11.1 Key Findings
11.2 Asia Pacific Hematology Diagnostics Market Overview
11.3 Asia Pacific Market Value Share Analysis, by Product Type
11.4 Asia Pacific Market Forecast, by Product Type
11.4.1 Hematology Instruments
11.4.2 Hematology Consumables
11.5 Asia Pacific Market Value Share Analysis, by Hematology Instruments
11.6 Asia Pacific Market Forecast, by Hematology Instruments
11.6.1 Hematology Analyzers
11.6.2 Flow Cytometers
11.6.3 Others
11.7 Asia Pacific Market Value Share Analysis, by Hematology Consumables
11.8 Asia Pacific Market Forecast, by Hematology Consumables
11.8.1 Reagents
11.8.2 Stains
11.8.3 Controls & Calibrators
11.8.4 Others
11.9 Asia Pacific Market Value Share Analysis, by End-user
11.10 Asia Pacific Market Forecast, by End-user
11.10.1 Diagnostic Laboratories
11.10.2 Hospitals & Clinics
11.10.3 Academic Institutes
11.10.4 Others
11.11 Market Analysis, by Country
11.12 Market Value Share Analysis, by Country
11.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026
11.13.1 China
11.13.2 Japan
11.13.3 India
11.13.4 Australia & New Zealand
11.13.5 Rest of Asia Pacific
11.14 Market Attractiveness Analysis
11.14.1 by Product Type
11.14.2 by Hematology Instruments
11.14.3 by Hematology Consumables
11.14.4 by End-user
11.14.5 by Country
Section 12 Latin America Hematology Diagnostics Market Analysis
12.1 Key Findings
12.2 Latin America Hematology Diagnostics Market Overview
12.3 Latin America Market Value Share Analysis, by Product Type
12.4 Latin America Market Forecast, by Product Type
12.4.1 Hematology Instruments
12.4.2 Hematology Consumables
12.5 Latin America Market Value Share Analysis, by Hematology Instruments
12.6 Latin America Market Forecast, by Hematology Instruments
12.6.1 Hematology Analyzers
12.6.2 Flow Cytometers
12.6.3 Others
12.7 Latin America Market Value Share Analysis, by Hematology Consumables
12.8 Latin America Market Forecast, by Hematology Consumables
12.8.1 Reagents
12.8.2 Stains
12.8.3 Controls & Calibrators
12.8.4 Others
12.9 Latin America Market Value Share Analysis, by End-user
12.10 Latin America Market Forecast, by End-user
12.10.1 Diagnostic Laboratories
12.10.2 Hospitals & Clinics
12.10.3 Academic Institutes
12.10.4 Others
12.11 Market Analysis, by Country
12.12 Market Value Share Analysis, by Country
12.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026
12.13.1 Brazil
12.13.2 Mexico
12.13.3 Rest of Latin America
12.14 Market Attractiveness Analysis
12.14.1 by Product Type
12.14.2 by Hematology Instruments
12.14.3 by Hematology Consumables
12.14.4 by End-user
12.14.5 by Country
Section 13 Middle East & Africa Hematology Diagnostics Market Analysis
13.1 Key Findings
13.2 Middle East & Africa Hematology Diagnostics Market Overview
13.3 Middle East & Africa Market Value Share Analysis, by Product Type
13.4 Middle East & Africa Market Forecast, by Product Type
13.4.1 Hematology Instruments
13.4.2 Hematology Consumables
13.5 Middle East & Africa Market Value Share Analysis, by Hematology Instruments
13.6 Middle East & Africa Market Forecast, by Hematology Instruments
13.6.1 Hematology Analyzers
13.6.2 Flow Cytometers
13.6.3 Others
13.7 Middle East & Africa Market Value Share Analysis, by Hematology Consumables
13.8 Middle East & Africa Market Forecast, by Hematology Consumables
13.8.1 Reagents
13.8.2 Stains
13.8.3 Controls & Calibrators
13.8.4 Others
13.9 Middle East & Africa Market Value Share Analysis, by End-user
13.10 Middle East & Africa Market Forecast, by End-user
13.10.1 Diagnostic Laboratories
13.10.2 Hospitals & Clinics
13.10.3 Academic Institutes
13.10.4 Others
13.11 Market Analysis, by Country
13.12 Market Value Share Analysis, by Country
13.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026
13.13.1 GCC Countries
13.13.2 South Africa
13.13.3 Rest of Middle East & Africa
13.14 Market Attractiveness Analysis
13.14.1 By Product Type
13.14.2 by Hematology Instruments
13.14.3 by Hematology Consumables
13.14.4 by End-user
13.14.5 by Country
Section 14 Competition Landscape
14.1 Competition Matrix
14.2 Hematology Diagnostics Market Share Analysis, by Company (2017)
14.3 Company Profiles
14.3.1 Abbott Laboratories
14.3.1.1 Company Description
14.3.1.2 Financial Overview
14.3.1.3 Strategy & Recent Developments
14.3.1.4 SWOT Analysis
14.3.2 Bio-Rad Laboratories, Inc.
14.3.2.1 Company Description
14.3.2.2 Financial Overview
14.3.2.3 Strategy & Recent Developments
14.3.2.4 SWOT Analysis
14.3.3 Sysmex Corporation
14.3.3.1 Company Description
14.3.3.2 Financial Overview
14.3.3.3 Strategy & Recent Developments
14.3.3.4 SWOT Analysis
14.3.4 Mindray Medical International Limited
14.3.4.1 Company Description
14.3.4.2 Financial Overview
14.3.4.3 Strategy & Recent Developments
14.3.4.4 SWOT Analysis
14.3.5 Siemens Healthineers
14.3.5.1 Company Description
14.3.5.2 Financial Overview
14.3.5.3 Strategy & Recent Developments
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche Ltd.
14.3.6.1 Company Description
14.3.6.2 Financial Overview
14.3.6.3 Strategy & Recent Developments
14.3.6.4 SWOT Analysis
14.3.7 HORIBA, Ltd.
14.3.7.1 Company Description
14.3.7.2 Financial Overview
14.3.7.3 Strategy & Recent Developments
14.3.7.4 SWOT Analysis
14.3.8 HemoCue AB
14.3.8.1 Company Description
14.3.8.2 Financial Overview
14.3.8.3 Strategy & Recent Developments
14.3.8.4 SWOT Analysis
14.3.9 Danaher (Beckman Coulter, Inc.)
14.3.9.1 Company Description
14.3.9.2 Financial Overview
14.3.9.3 Strategy & Recent Developments
14.3.9.4 SWOT Analysis
14.3.10 Nihon Kohden Corporation
14.3.10.1 Company Description
14.3.10.2 Financial Overview
14.3.10.3 Strategy & Recent Developments
14.3.10.4 SWOT Analysis
14.3.11 EKF Diagnostics
14.3.11.1 Company Description
14.3.11.2 Financial Overview
14.3.11.3 Strategy & Recent Developments
14.3.11.4 SWOT Analysis
14.3.12 Ortho Clinical Diagnostics
14.3.12.1 Company Description
14.3.12.2 Financial Overview
14.3.12.3 Strategy & Recent Developments
14.3.12.4 SWOT Analysis
14.3.13 Drew Scientific
14.3.13.1 Company Description
14.3.13.2 Financial Overview
14.3.13.3 Strategy & Recent Developments
14.3.13.4 SWOT Analysis
Hematology Diagnostics Market Reports - List of Tables
Table 01: Global Hematology diagnostics Market Analysis, by Installed Base
Table 02: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 03: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026
Table 04: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026
Table 05: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026
Table 06: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 07: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 08: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 09: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 10: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026
Table 11: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026
Table 12: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026
Table 13: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 14: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 15: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 16: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026
Table 17: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026
Table 18: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026
Table 19: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 20: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 22: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026
Table 23: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026
Table 24: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026
Table 25: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 26: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 27: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 28: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026
Table 29: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026
Table 30: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026
Table 31: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 32: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 33: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 34: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026
Table 35: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026
Table 36: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026
Table 37: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Hematology Diagnostics Market Reports - List of Figures
Figure 01: Global Hematology Diagnostics Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 02: Global Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 03: Hematology Diagnostics Market Value Share, by Product Type, 2017
Figure 04: Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017
Figure 05: Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017
Figure 06: Hematology Diagnostics Market Value Share, by Region, 2017
Figure 07: Expected New Cases of Leukemia, Lymphoma, or Myeloma in 2017
Figure 08: Global Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026
Figure 09: Global Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026
Figure 10: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hematology Analyzers, 2016–2026
Figure 11: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Flow Cytometers, 2016–2026
Figure 12: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 13: Global Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026
Figure 14: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents, 2016–2026
Figure 15: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stains, 2016–2026
Figure 16: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Controls & Calibrators, 2016–2026
Figure 17: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 19: Global Hematology Diagnostics Market Attractiveness Analysis, by Hematology Instruments, 2018–2026
Figure 18: Global Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 20: Global Hematology Diagnostics Market Attractiveness Analysis, by Hematology Consumables, 2018–2026
Figure 21: Global Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026
Figure 22: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2016–2026
Figure 23: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & Clinics, 2016–2026
Figure 24: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic Institutes, 2016–2026
Figure 25: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 26: Global Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2018–2026
Figure 27: Global Hematology Diagnostics Market Value Share, by Region, 2017 and 2026
Figure 28: Global Hematology Diagnostics Market Attractiveness Analysis, by Region, 2018–2026
Figure 29: North America Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 30: North America Hematology Diagnostics Market Value Share, by Country, 2017 and 2026
Figure 31: North America Hematology Diagnostics Market Attractiveness, by Country, 2018–2026
Figure 32: North America Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026
Figure 33: North America Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026
Figure 34: North America Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026
Figure 35: North America Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026
Figure 36: North America Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026
Figure 37: North America Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026
Figure 38: North America Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026
Figure 39: North America Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026
Figure 40: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 41: Europe Hematology Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 42: Europe Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 43: Europe Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026
Figure 44: Europe Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026
Figure 45: Europe Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026
Figure 46: Europe Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026
Figure 47: Europe Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026
Figure 48: Europe Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026
Figure 49: Europe Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026
Figure 50: Europe Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026
Figure 51: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 52: Asia Pacific Hematology Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 53: Asia Pacific Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 54: Asia Pacific Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026
Figure 55: Asia Pacific Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026
Figure 56: Asia Pacific Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026
Figure 57: Asia Pacific Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026
Figure 58: Asia Pacific Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026
Figure 59: Asia Pacific Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026
Figure 60: Asia Pacific Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026
Figure 61: Europe Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026
Figure 62: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 63: Latin America Hematology Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 64: Latin America Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 65: Latin America Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026
Figure 66: Latin America Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026
Figure 67: Latin America Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026
Figure 68: Latin America Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026
Figure 69: Latin America Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026
Figure 70: Latin America Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026
Figure 71: Latin America Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026
Figure 72: Latin America Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026
Figure 73: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 74: Middle East & Africa Hematology Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 75: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 76: Middle East & Africa Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026
Figure 77: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026
Figure 78: Middle East & Africa Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026
Figure 79: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026
Figure 80: Middle East & Africa Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026
Figure 81: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026
Figure 82: Middle East & Africa Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026
Figure 83: Middle East & Africa Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026